U.S. markets open in 1 hour 55 minutes

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
122.54+2.40 (+2.00%)
At close: 4:00PM EDT
123.00 +0.46 (0.38%)
Pre-Market: 07:12AM EDT
Full screen
Loading interactive chart...
  • Dovetail Genomics Announces New Capture Hi-C Targeted Enrichment Panels
    PR Newswire

    Dovetail Genomics Announces New Capture Hi-C Targeted Enrichment Panels

    Dovetail Genomics, the industry leader in advanced proximity ligation genomic solutions, today announced availability of its new line of capture Hi-C technology. The flagship products include two targeted enrichment panels, the Dovetail® Human Pan Promoter Enrichment Kit, and the Dovetail® Mouse Pan Promoter Enrichment Kit, enabling the interrogation of chromatin topology surrounding 80,000 coding and non-coding gene promoters for human and mouse samples respectively. Dovetail's solution incorpo

  • Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening
    Business Wire

    Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening

    SOUTH SAN FRANCISCO, Calif., Jun 14, 2021--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it collaborated with Regeneron Genetics Center LLC (RGC), a wholly-owned subsidiary of Regeneron (Nasdaq: REGN), for the production of a custom next-generation sequencing (NGS) population genetics genotyping assay. Arising from a need to incorporate the genetic differences of

  • Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital
    Business Wire

    Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital

    SOUTH SAN FRANCISCO, Calif., Jun 14, 2021--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that CEO Emily Leproust will participate in a fireside chat at the BIO Digital conference being held virtually from June 10-11 and 14-18, 2021. Dr. Leproust’s chat with moderator Catherine Schulte, Senior Research Analyst from Baird will be shown at 3 pm EDT on June 17 and wil